Your browser doesn't support javascript.
loading
Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group.
Al-Sawaf, O; Robrecht, S; Bahlo, J; Fink, A M; Cramer, P; von Tresckow, J; Maurer, C; Bergmann, M; Seiler, T; Lange, E; Kneba, M; Stilgenbauer, S; Döhner, H; Kiehl, M G; Jäger, U; Wendtner, C M; Fischer, K; Goede, V; Hallek, M; Eichhorst, B; Hopfinger, G.
Afiliación
  • Al-Sawaf O; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Robrecht S; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Bahlo J; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Fink AM; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Cramer P; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • von Tresckow J; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Maurer C; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Bergmann M; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Hospital Munich-Schwabing, Munich, Germany.
  • Seiler T; Medical Department III, University Hospital of the Ludwig-Maximilians-University, Munich, Germany.
  • Lange E; Department of Hematology and Oncology, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • Kneba M; Second Department of Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, German CLL Study Group, University Hospital of Ulm, Ulm, Germany.
  • Döhner H; Department of Internal Medicine III, German CLL Study Group, University Hospital of Ulm, Ulm, Germany.
  • Kiehl MG; Department of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt/Oder, Germany.
  • Jäger U; Division of Hematology and Hemostaeology, Department of Internal Medicine I, Medical University Vienna, Vienna, Austria.
  • Wendtner CM; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Hospital Munich-Schwabing, Munich, Germany.
  • Fischer K; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Goede V; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Eichhorst B; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Germany.
  • Hopfinger G; Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria.
Leukemia ; 31(10): 2251-2253, 2017 10.
Article en En | MEDLINE | ID: mdl-28745332

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Systematic_reviews Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Systematic_reviews Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania